These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 26691725)

  • 41. Neurocognitive functioning in the premorbid stage and in the first episode of bipolar disorder: a systematic review.
    Martino DJ; Samamé C; Ibañez A; Strejilevich SA
    Psychiatry Res; 2015 Mar; 226(1):23-30. PubMed ID: 25618475
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neurocognitive markers of psychosis in bipolar disorder: a meta-analytic study.
    Bora E; Yücel M; Pantelis C
    J Affect Disord; 2010 Dec; 127(1-3):1-9. PubMed ID: 20231037
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cognitive performances across individuals at high genetic risk for schizophrenia, high genetic risk for bipolar disorder, and low genetic risks: a combined polygenic risk score approach.
    Ohi K; Nishizawa D; Sugiyama S; Takai K; Fujikane D; Kuramitsu A; Hasegawa J; Soda M; Kitaichi K; Hashimoto R; Ikeda K; Shioiri T
    Psychol Med; 2023 Jul; 53(10):4454-4463. PubMed ID: 35971752
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association of distinct allelic haplotypes of DISC1 with psychotic and bipolar spectrum disorders and with underlying cognitive impairments.
    Palo OM; Antila M; Silander K; Hennah W; Kilpinen H; Soronen P; Tuulio-Henriksson A; Kieseppä T; Partonen T; Lönnqvist J; Peltonen L; Paunio T
    Hum Mol Genet; 2007 Oct; 16(20):2517-28. PubMed ID: 17673452
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neurocognitive growth charting in psychosis spectrum youths.
    Gur RC; Calkins ME; Satterthwaite TD; Ruparel K; Bilker WB; Moore TM; Savitt AP; Hakonarson H; Gur RE
    JAMA Psychiatry; 2014 Apr; 71(4):366-74. PubMed ID: 24499990
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Schizophrenia and manic-depression: separate illnesses or a continuum?
    Lapierre YD
    Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S59-64. PubMed ID: 7874666
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Neurocognitive functioning in euthymic patients with bipolar type I disorder].
    Dias VV; Brissos S; Martinez-Arán A; Kapczinski F
    Acta Med Port; 2008; 21(6):527-38. PubMed ID: 19331785
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differential working memory impairment in bipolar disorder and schizophrenia: effects of lifetime history of psychosis.
    Glahn DC; Bearden CE; Cakir S; Barrett JA; Najt P; Serap Monkul E; Maples N; Velligan DI; Soares JC
    Bipolar Disord; 2006 Apr; 8(2):117-23. PubMed ID: 16542181
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The course of neuropsychological impairment and brain structure abnormalities in psychotic disorders.
    Woodward ND
    Neurosci Res; 2016 Jan; 102():39-46. PubMed ID: 25152315
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Associations of NEUROD2 polymorphisms and change of cognitive dysfunctions in schizophrenia and schizoaffective disorder after eight weeks of antipsychotic treatment.
    Spellmann I; Riedel M; Städtler J; Zill P; Obermeier M; Cerovecki A; Dehning S; Schennach R; Epple M; Opgen-Rhein M; Müller N; Bondy B; Möller HJ; Musil R
    Cogn Neuropsychiatry; 2017 Jul; 22(4):280-297. PubMed ID: 28470106
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An empirical evaluation of the MATRICS Consensus Cognitive Battery in bipolar disorder.
    Van Rheenen TE; Rossell SL
    Bipolar Disord; 2014 May; 16(3):318-25. PubMed ID: 24119238
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serum levels of second-generation antipsychotics are associated with cognitive function in psychotic disorders.
    Steen NE; Aas M; Simonsen C; Dieset I; Tesli M; Nerhus M; Gardsjord E; Mørch R; Agartz I; Melle I; Ueland T; Spigset O; Andreassen OA
    World J Biol Psychiatry; 2017 Sep; 18(6):471-482. PubMed ID: 27712130
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differential patterns of neuropsychological performance in the euthymic and depressive phases of bipolar disorders.
    Ha TH; Chang JS; Oh SH; Kim JS; Cho HS; Ha K
    Psychiatry Clin Neurosci; 2014 Jul; 68(7):515-23. PubMed ID: 24612064
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Shared and distinct neurocognitive endophenotypes of schizophrenia and psychotic bipolar disorder.
    Kim D; Kim JW; Koo TH; Yun HR; Won SH
    Clin Psychopharmacol Neurosci; 2015 Apr; 13(1):94-102. PubMed ID: 25912542
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neurocognitive function in clinically stable men with bipolar I disorder or schizophrenia and normal control subjects.
    Altshuler LL; Ventura J; van Gorp WG; Green MF; Theberge DC; Mintz J
    Biol Psychiatry; 2004 Oct; 56(8):560-9. PubMed ID: 15476685
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bridging the gap between schizophrenia and psychotic mood disorders: Relating neurocognitive deficits to psychopathology.
    Smith MJ; Barch DM; Csernansky JG
    Schizophr Res; 2009 Jan; 107(1):69-75. PubMed ID: 18786811
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Do sleep disturbances contribute to cognitive impairments in schizophrenia spectrum and bipolar disorders?
    Laskemoen JF; Büchmann C; Barrett EA; Collier-Høegh M; Haatveit B; Vedal TJ; Ueland T; Melle I; Aas M; Simonsen C
    Eur Arch Psychiatry Clin Neurosci; 2020 Sep; 270(6):749-759. PubMed ID: 31587109
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neurocognitive impairments in individuals at ultra-high risk for psychosis: Who will really convert?
    Bang M; Kim KR; Song YY; Baek S; Lee E; An SK
    Aust N Z J Psychiatry; 2015 May; 49(5):462-70. PubMed ID: 25425742
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evolution of neuropsychological dysfunction during the course of schizophrenia and bipolar disorder.
    Lewandowski KE; Cohen BM; Ongur D
    Psychol Med; 2011 Feb; 41(2):225-41. PubMed ID: 20836900
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Exploring the borders of the schizoaffective spectrum: a categorical and dimensional approach.
    Peralta V; Cuesta MJ
    J Affect Disord; 2008 May; 108(1-2):71-86. PubMed ID: 18029027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.